Home / NATCOPHARM.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does NATCOPHARM.NS make money? Does NATCOPHARM.NS have pricing power? What's the Earnings Whisper? Will NATCOPHARM.NS profit more as the business scales? What is NATCOPHARM.NS's management track record? Is NATCOPHARM.NS's current price justified?

NATCO Pharma Limited

₹785.05 -$103.15 (-11.61%)

NSE · 16 Oct 2026 10:00 UTC

Previous Close

₹784.95

Day Range

₹780.95₹788.5

Year Range

₹779₹1226.8

Market Cap

144.45B

AVG Volume

516.98K

Trailing/Forward PE

12.29/15.69

PEG ratio

-0.3

Dividend Yield

0.57%

Next Earnings Date

2026-11-17

Primary Exchange

National Stock Exchange of India

Revenue (INR) · TTM

NATCOPHARM.NS Revenue (INR) by quarter, trailing twelve months
Period	Revenue (INR)
27 Q1	34.85B
26 Q4	40.78B
26 Q3	45.63B
26 Q2	43.9B
26 Q1	43.98B
25 Q4	44.32B
25 Q3	42.8B
25 Q2	45.64B
25 Q1	42.24B
24 Q4	40.02B

Net Income (INR) · TTM

NATCOPHARM.NS Net Income (INR) by quarter, trailing twelve months
Period	Net Income (INR)
27 Q1	11.44B
26 Q4	14.19B
26 Q3	15.57B
26 Q2	15.39B
26 Q1	16.98B
25 Q4	18.85B
25 Q3	18.65B
25 Q2	19.45B
25 Q1	16.36B
24 Q4	13.88B

Operating Income (INR) · TTM

NATCOPHARM.NS Operating Income (INR) by quarter, trailing twelve months
Period	Operating Income (INR)
27 Q1	8.56B
26 Q4	12.3B
26 Q3	18.2B
26 Q2	19.58B
26 Q1	24.73B
25 Q4	30B
25 Q3	29.55B
25 Q2	31.79B
25 Q1	28.3B
24 Q4	25.96B

EBITDA · TTM

Cash Flows · TTM

EPS · TTM

Expenses · TTM

Cash & Debt · TTM

Debt ratios · TTM

Margins · TTM

Return on Capital · TTM

Shares Outstanding · TTM

Dividends (INR) · TTM

Employee Count

Book Value Per Share · TTM

Total Assets · TTM

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

NATCO Pharma Limited

Video analysis: NATCOPHARM.NS

News: NATCOPHARM.NS

Similar companies